Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroids for Post-Infectious Olfactory Dysfunction
NCT04918953Phase 2Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jun 2021
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of methylprednisolone and budesonide in Olfactory dysfunction (3 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Overall Effective Rate at 5 years. Planned start Jun 2021; status: not yet recruiting.
02
Drugs
methylprednisolonebudesonide
03
Conditions
Olfactory dysfunction
Beyond the preview
Go deeper on NCT04918953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04918953.